« Back
Home /
LX-4211

LX-4211

Item no.	M5249-10mg
Manufacturer	AbMole
CASRN	1018899-04-1
Amount	10mg
Category	Oncology Neuroscience Metabolism Diabetes Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Pancreatic Cancer Nervous System Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Sotagliflozin; LP-802034
Available
Target Information	SGLT
Molecular Weight	424, 94
Solubility	84 mg/mL in DMSO
Bioactivity information	LX-4211 is an orally active, first-in-class dual SGLT1/2 inhibitor with IC50s of 36 nM and 1.8 nM, respectively, and is used in studies related to type 1 diabetes and heart failure.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M5249-10mg-safety-datasheet.pdf